<DOC>
	<DOCNO>NCT02729415</DOCNO>
	<brief_summary>Androgenetic alopecia ( AGA ) common form hair loss affect 50 % 23 % Caucasian men woman , respectively , age 50 . The percentage men woman affect age 70 increase 80 % 60 % Caucasian men woman , respectively . Although alopecia consider minor dermatologic condition , see serious condition major life consequence alopecia associate increased incidence myocardial infarction , hypertension hypercholesterolaemia . Androgenetic alopecia associate feeling anxiety , depression various personality disorder among men woman due physical appearance . Depression , anxiety , aggressiveness , impaired quality life social inadequacy document . The presence alopecia woman particularly stressful . ADSCs ( Adipose Derived Stromal Cells ) , also call Stromal Vascular Fraction ( SVF ) cell , include regenerative cell population derive adipose tissue thus potentially important multiple disease process therapeutic application repair regeneration acute chronically damage tissue . It postulate SVF cell may promote hair regeneration increase hair-inducing ability dermal papilla ( DP ) cell . The general objective study conduct safety feasibility study single injection autologous adipose-derived SVF cell treatment alopecia .</brief_summary>
	<brief_title>Point-of-Care Adipose-derived Cells Hair Growth</brief_title>
	<detailed_description>This prospective , non-randomized , non-blinded , interventional , consecutive series , single site study determine initial safety feasibility single injection autologous adipose-derived SVF cell treatment alopecia . Up 8 subject diagnose androgenetic alopecia ask participate . Before procedure density ( number hair per square centimeter ) thickness ( mm ) hair measure compare measurement procedure . All adverse event record evaluated severity . Subjects ask come office follow day : pre-procedure visit , 24 hour post procedure visit , 6 week post procedure visit , 3 month post procedure visit 6 month post procedure visit .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Subjects good health ( ASA Class III ) BMI &lt; 35 . Must least 2cm x 2cm spot scalp show evidence alopecia without scar traumatic injury Able willing make require study visit . Able willing give consent follow study instruction . Must speak , read understand English History bleeding disorder , anticoagulation therapy stop 14 day prior injection Allergic lidocaine , epinephrine , Vancomycin , cephalexins , cephalosporin , penicillin chlorhexidine gluconate Individuals propensity keloid Individuals diminish decisionmaking capacity include research study . Current use antiinflammatory anticoagulation medication affect bleed bleeding disorder . These include : Plavix , Warfarin ( Coumadin , Jantoven , Marfarin ) . Use concomitant treatment improve hair growth , include topical medication , oral medication , mesotherapy , nonablative fractional laser treatment , lowlevel laser therapy , interfollicular PRP injection hair transplantation within precede 6 month . Smoking tobacco use . Pregnancy lactate period female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hair Diseases</keyword>
	<keyword>Alopecia</keyword>
</DOC>